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Compared to pharmacology, the efficacy of surgery has
been very poorly evaluated. Many surgical procedures
are carried out on a daily basis without any good evi-
dence to support them. Primarily this is because the
methodology for surgical trials offers some unique chal-
lenges. Whilst a comparison between two (or more) sur-
gical procedures is possible, such a model only provides
information on relative efficacy. It does not address the
fundamental issue of whether the treatment provides
any more benefit than the significant placebo effect
obtained from undergoing a surgical procedure. A pla-
cebo controlled comparison is therefore preferred, but
there are several ethical, implementation and interpreta-
tion obstacles to overcome before the design can be
accepted as standard.
Using a current example of a placebo controlled surgi-
cal trial of shoulder surgery (CSAW), a number of issues
surrounding placebo controlled surgical trials will be
explored. These will include; which designs can be used
to account for the placebo effect, what constitutes “pla-
cebo” surgery, how to identify and manipulate the “criti-
cal surgical element” (CSE) and operational problems
associated with placebo surgical trials.
The objective of the paper is to share recent experi-
ences and derived knowledge to help with future pla-
cebo controlled surgical trial design.
Published: 29 November 2013
doi:10.1186/1745-6215-14-S1-P11
Cite this article as: Beard et al.: Accounting for the placebo effect of
surgery in surgical trials? Trials 2013 14(Suppl 1):P11.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
University of Oxford, Oxford, UK
Beard et al. Trials 2013, 14(Suppl 1):P11
http://www.trialsjournal.com/content/14/S1/P11 TRIALS
© 2013 Beard et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
